Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia
Clinical trial NCT07530666 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07530666
- Sponsor
- Dartsbio Pharmaceuticals Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2027-10-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.